UUID: BDIFBOFF-1756-4209-843E-2FZBF2EBCCC2

TCGA-EY-AZOQ-BlA-PR Redacted
|||||||IllIIIIIIIIIHIIIII|||||||||||||||||||||||||||||||I||||| HOLOGY REVISED REPORT
l|||||||||||l||||||||||||||||||||||||||||||||||||||||||||||I A 0 3
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| /¢ , « ‘

aabnoauaaumuglﬂdbnﬂhu"1”*3
Diagnosis: S‘ﬁiW/W‘rw 657/1 €380/3
A: Vulva, biopsy /A/qum

— Skin with hyperkeratosis, marked dermal sclerosis, and chronic
inflammation consistent with lichen sclerosus

— Tangential sectioning artifact present

- No evidence of dysplasia, HPV effect, or malignancy

B: Lymph node, sentinel, periaortic #1, right, biopsy
- One lymph node, no tumor seen, based on evaluation of 3 H & E
levels per block (0/1)

C: Lymph node, sentinel, periaortic #2, right, biopsy
- One lymph node, no tumor seen, based on evaluation of 3 H & E
levels per block (O/l)

D: Lymph node, sentinel, periaortic #1, left, biopsy
— One lymph node, no tumor seen, based on evaluation of 3 H & E
levels per block (0/1)

E: Lymph nodes, periaortic, left, removal
- Ten lymph nodes, many which are quite minute, no tumor seen
(0/10)

F: Lymph node, sentinel, pelvic lymph node #1, right, removal
— One lymph node, no tumor seen, based on evaluation of 3 H & E
levels per block (0/1)

G: Lymph node, pelvic, sentinel #2, right, biopsy
- One lymph node, no tumor seen, based on evaluation of 3 H & E
levels per block (0/1)

H: Lymph node, sentinel, pelvic, left, biopsy
- One lymph node, no tumor seen, based on evaluation of 3 H & E
levels per block (0/1)

I: Uterus, cervix, hysterectomy and bilateral salpingo—
oophorectomy

Location of tumor: endometrium

Histologic type: endometrioid adenocarcinoma with focal squamous
differentiation (14)

 

Histologic grade (FIGO): overall FIGO grade 3 (architectural
grade 2, nuclear grade 3) (I4)

Extent of invasion:

Myometrial invasion: Inner half

Depth: 0.5 cm Wall thickness: 1.7 cm

Percent: 29% (12)

Serosal involvement: absent

Lower uterine segment involvement: absent

Cervical involvement: absent

Adnexal involvement (see below): absent

Other sites: not applicable

Cervical/vaginal margin and distance: widely free of tumor
Lymphovascular Space Invasion: absent

Regional lymph nodes (see other specimens):

Total number involved: 0

Total number examined: 37

Other Pathologic findings: none

Tumor estrogen receptor and progesterone receptor
immunohistochemistry results: pending; final results will be

issued in an addendum report (I4)

AJCC Pathologic stage: pTla pNO pr
FIGO (2008 classification) Stage grouping: IA

These stages are based on information available at the time of
this report, and are subject to change pending additional
information and clinical review

Ovary, right, oophorectomy:
- Atrophic ovary, no tumor seen

Ovary, left, oophorectomy:
- Atrophic ovary, no tumor seen

Fallopian tube, right, salpingectomy:
- No tumor seen

Fallopian tube, left, salpingectomy:
— No tumor seen

J: Soft tissue, pelvic nodes, right, removal
- Thirteen lymph nodes, no tumor seen (0/13)

K: Soft tissue, pelvic nodes, left, removal
Six lymph nodes, no tumor seen {0/6)

t“

Soft tissue, right periaortic nodes, removal
Two lymph nodes, no tumor seen (0/2)

Clinical History:
Right vulvar epithelium and grade III endometrial cancer.

Gross Description:
Specimen A is labeled "V 7 ' and holds a 2 x 2 x 2 mm
white firm tissue fragment, A1, ‘

Specimen B is labeled ":
4 ' " and holds a 1. 5 x 1.1 x 0.5 cm yellow firm tissue
fragment. The tissue fragment is bisected and submitted in B1,

Specimen C is labeled " ' " ' ‘

' and holds two fragments of yellow lobulated adipose
tissue, 1. 6 x 1. 5 x 0.5 cm in aggregate. No lymph node tissue is
palpated within the fragment, which is submitted in C1,

Specimen D is labeled " g _,
and holds a 2.5 x 1.1 x 0.5 cm fragment of yellow firm
adipose tissue. The fragment is bisected and submitted in D1,

Specimen E is labeled "' ‘ ' " ‘ ‘ " and
holds a 3. 3 x 2. 5 x 1. 5 cm aggregate of yellow lobulated adipose
tissue. Within the fragments are multiple lymph node candidates
measuring up to 0.5 cm in greatest dimension. The specimen is
submitted in E1—E3,

Specimen F is labeled "r _ ‘ Vi

a , _ " and holds a 2.5 x 2.0 x 0.6 cm fragment of yellow

lobulated adipose tissue. The fragment is bisected and submitted
in F1—F2,

Specimen G is labeled "2 ‘ ' " -- #2,
biopsy" and holds a 1. 6 x 1. 0 x 0. 4 cm fragment of yellow
lobulated adipose tissue which is submitted in G1,

Specimen H is labeled "
and holds a 1. 9 x 0. 4 x 0. 4 cm fragment of yellow focally
cauterized tissue, which is submitted in H1,

Specimen I is received is one appropriately labeled container.

Adnexa: Present

Weight: 124.3 grams

Shape: Pear

Dimensions:

height: 9.4 cm

anterior to posterior width: 4.4 cm

breadth at fundus: 7.0 cm

Serosa: Tan/pink with focal erythema on the anterior wall.
Cervix: 2. 7 x 2. 5 cm with a 0.9 cm patent 08.
length of endocervical canal: 1. 5 cm
ectocervix: Tan/pink with diffuse erythema
endocervix: Tan and trabeculated
Endomyometrium:

length of endometrial cavity: 3.9 cm

width of endometrial cavity at fundus: 2.8 cm
tumor findings:

dimensions: 4.0 x 3.7 x 1.2 cm

appearance: Tan/pink soft and exophytic
location and extent: The majority is on the posterior corpus
extending to involve the anterior upper corpus
myometrial invasion: No apparent invasion

thickness of myometrial wall at deepest gross invasion: 2.1 cm
other findings or comments: The uninvolved endometrium is
tan/firm and up to 0.2 cm thick. The myometrium is focally
trabeculated. There is single white rubbery nodule within the
posterior wall 0.4 cm in greatest dimension

Adnexa:

Right ovary:

dimensions: 3.1 x 2.1 x 1.0 cm

external surface: Tan/pink and glistening
cut surface: Tan/white and unremarkable

Right fallopian tube: (Previous tubal ligation)

dimensions: Distal end 1.5 cm in length x 0.4 cm in diameter;
proximal end 1.1 cm in length x 0.4 cm in diameter

other findings: The outer surface is tan/pink and glistening and
the lumen is patent.

Left ovary:

dimensions: 2.5 x 1.1 x 1.0 cm

external surface: Tan/pink and smooth

cut surface: Tan/white firm and unremarkable

Left fallopian tube:

dimensions: 1.5 cm in length x 0.4 cm in diameter

other findings: The outer surface is tan/pink and glistening and
the cut surface reveals a patent unremarkable lumen.

Lymph nodes: See remaining parts
Other comments:
Digital photograph taken:

Tissue submitted for special investigations: Tissue submitted to
tissue
procurement.

Block Summary:

I1 — Anterior cervix, lower uterine segment

I2 - Full thickness tumor at fundus

13 — Tumor anterior wall

I4 - Tumor full thickness posterior wall to include myometrial
nodule

I5 — Uninvolved endomyometrium, anterior wall

I6 - Posterior cervix, lower uterine segment

I7 ~ Right ovary and fallopian tube

I8 - Left ovary and fallopian tube

Specimen J is labeled ". ' ' ." and holds a
9.0 x 3.6 x 1.1 cm aggregate of yellow lobulated adipose tissue.
Within the fragments there are multiple lymph node candidates.
The largest is 2 cm in greatest dimension. The specimen is
submitted in eight cassettes per block summary.

Block Summary:
Jl-J6 - Multiple lymph node candidates, each cassette
J7—J8 — One lymph node candidate, bisected

Specimen K is labeled "f " and
holds multiple fragments of yellow firm adipose tissue, 4.5 x
4.2 x 1.5 cm in aggregate. Both fragments contain multiple lymph
node candidates, the largest is 2.2 cm in greatest dimension.
The specimen is sampled in 8 cassettes per block summary.

Block Summary:

K1—K3 - Multiple lymph node candidates in each cassette
K4-K5 — One lymph node candidate bisected

K6~K7 — One lymph node candidate bisected

K8 - Adipose tissue, adipose tissue remains in formalin

Specimen L is labeled " g r. ‘ “‘ "
and holds a 7.2 x 3.6 x 0.8 cm aggregate of yellow lobulated
adipose tissue fragments. In the fragments there are two lymph
node candidates up to 1.5 cm in greatest dimension. The specimen
is submitted in four cassettes per block summary.

Block Summary:

L1 - One lymph node candidate
L2 — One lymph node candidate
L3—L4 — Adipose tissue,

Procedures/Addenda:
Addendum

Addendum

Immunostains for ER and PR are performed on a representative
block of endometrial tumor (I4). The tumor is ER negative (0)
and PR negative (2+, (1%).

